Predictors of Clinical Outcome in Women with Pelvic Organ Prolapse Who Underwent Transvaginal Mesh Reconstruction Surgery.

Ting-Hsuan Lin, Fung-Chao Tu, Ho-Hsiung Lin, Sheng-Mou Hsiao
Author Information
  1. Ting-Hsuan Lin: Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei 220409, Taiwan.
  2. Fung-Chao Tu: Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei 220409, Taiwan.
  3. Ho-Hsiung Lin: Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei 220409, Taiwan.
  4. Sheng-Mou Hsiao: Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei 220409, Taiwan. ORCID

Abstract

: To identify the predictors of clinical outcomes in women with pelvic organ prolapse (POP) who underwent transvaginal reconstruction surgery, especially with transobturator mesh fixation or sacrospinous mesh fixation. : All women with POP who underwent transvaginal reconstruction surgery, especially with transobturator mesh fixation or sacrospinous mesh fixation, were reviewed. Between January 2011 and May 2019, a total of 206 consecutive women were reviewed, including 68 women receiving POP reconstruction with transobturator mesh fixation and 138 women who underwent POP reconstruction with sacrospinous mesh fixation. The least experienced surgeon (hazard ratio = 804.6) and advanced stage of cystocele (hazard ratio = 8.80) were the predictors of POP recurrence, especially those women with stage 4 of cystocele. Young age (hazard ratio = 0.94) was a predictor for mesh extrusion, especially those women with age ≤67 years. Follow-up interval (odds ratio = 1.03, = 0.02) was also an independent predictor of mesh extrusion. High maximum flow rate (Qmax, hazard ratio = 1.03) was the sole predictor of postoperative stress urinary incontinence, especially those women with Qmax ≥19.2 mL/s. Preoperative overactive bladder syndrome (hazard ratio = 3.22) were a predictor for postoperative overactive bladder syndrome. In addition, overactive bladder syndrome rate improved after surgery in the sacrospinous group ( = 0.0001). Voiding dysfunction rates improved after surgery in both sacrospinous and transobturator groups. Predictors of clinical outcome in women who underwent transvaginal POP mesh reconstruction are identified. The findings can serve as a guide for preoperative consultation of similar procedures.

Keywords

References

  1. J Am Geriatr Soc. 2009 Aug;57(8):1362-8 [PMID: 19558473]
  2. Int J Urol. 2012 Jun;19(6):494-5 [PMID: 22409331]
  3. Int Urogynecol J. 2010 Sep;21(9):1143-9 [PMID: 20419366]
  4. Obstet Gynecol. 2013 Nov;122(5):981-987 [PMID: 24104778]
  5. Taiwan J Obstet Gynecol. 2018 Dec;57(6):853-857 [PMID: 30545540]
  6. Int Urogynecol J. 2021 Aug;32(8):2291-2293 [PMID: 33730231]
  7. Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:203-210 [PMID: 33152564]
  8. Obstet Gynecol. 2016 Feb;127(2):341-7 [PMID: 26942363]
  9. Int Urogynecol J. 2019 Jul;30(7):1147-1152 [PMID: 29869693]
  10. Female Pelvic Med Reconstr Surg. 2019 May/Jun;25(3):200-205 [PMID: 29232268]
  11. Biomed Res Int. 2015;2015:479610 [PMID: 25893193]
  12. Urology. 2020 Mar;137:190-195 [PMID: 31883878]
  13. World J Urol. 2016 Oct;34(10):1491-8 [PMID: 26906029]
  14. Turk J Urol. 2020 Feb 07;46(2):134-139 [PMID: 32053097]
  15. Am J Obstet Gynecol. 2007 Jul;197(1):82.e1-4 [PMID: 17618768]
  16. Int Urogynecol J. 2012 Dec;23(12):1753-61 [PMID: 22531956]
  17. Int J Urol. 2021 Feb;28(2):202-207 [PMID: 33169395]
  18. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):224-7 [PMID: 22326614]
  19. Int Urogynecol J. 2018 Feb;29(2):297-306 [PMID: 28577172]
  20. Int J Urol. 2011 Mar;18(3):219-24 [PMID: 21219445]
  21. Menopause. 2011 Mar;18(3):328-32 [PMID: 20980929]
  22. Int Urogynecol J. 2021 Apr;32(4):819-827 [PMID: 32970175]
  23. Curr Opin Obstet Gynecol. 2011 Oct;23(5):366-70 [PMID: 21836508]
  24. Neurourol Urodyn. 2021 Feb;40(2):659-665 [PMID: 33348447]
  25. Eur J Obstet Gynecol Reprod Biol. 2019 Aug;239:30-34 [PMID: 31163354]
  26. Biomed Res Int. 2015;2015:191258 [PMID: 26634203]
  27. Menopause Int. 2008 Dec;14(4):145-8 [PMID: 19037062]
  28. Int Urogynecol J. 2010 Jan;21(1):5-26 [PMID: 19937315]
  29. Soc Sci Med. 1996 Jun;42(11):1537-44 [PMID: 8771636]
  30. Female Pelvic Med Reconstr Surg. 2012 Nov-Dec;18(6):357-61 [PMID: 23143431]
  31. Int Urogynecol J. 2015 Mar;26(3):391-400 [PMID: 25257810]
  32. World J Urol. 2018 Feb;36(2):299-304 [PMID: 29170793]
  33. Int J Urol. 2019 Jul;26(7):731-736 [PMID: 31066098]
  34. Int Urogynecol J. 2018 Jan;29(1):13-21 [PMID: 28921033]
  35. Am J Obstet Gynecol. 2006 Dec;195(6):1837-40 [PMID: 17132485]
  36. Maturitas. 2017 May;99:73-78 [PMID: 28364872]
  37. Int J Urol. 2015 Jun;22(6):577-80 [PMID: 25754989]
  38. Int Urogynecol J. 2016 Jul;27(7):1075-80 [PMID: 26811116]
  39. J Urol. 2015 Sep;194(3):721-7 [PMID: 25837536]
  40. Int Urogynecol J. 2016 Sep;27(9):1337-45 [PMID: 26874525]
  41. BMC Womens Health. 2018 Oct 25;18(1):174 [PMID: 30359244]
  42. Urol Int. 2021;105(1-2):137-142 [PMID: 33075779]
  43. J Urol. 2013 Jan;189(1):200-3 [PMID: 23174246]

MeSH Term

Aged
Cystocele
Female
Humans
Pelvic Organ Prolapse
Surgical Mesh
Treatment Outcome
Urinary Incontinence, Stress

Word Cloud

Created with Highcharts 10.0.0meshwomen=POPfixationratioreconstructionespeciallysacrospinoushazardunderwentsurgerytransobturatorpredictoroveractivebladdertransvaginal0urinarysyndrome:predictorsclinicalpelvicorganprolapsereviewedstagecystoceleageextrusion103rateQmaxpostoperativestressincontinenceimprovedPredictorsidentifyoutcomesJanuary2011May2019total206consecutiveincluding68receiving138leastexperiencedsurgeon8046advanced880recurrence4Young94≤67yearsFollow-upintervalodds02alsoindependentHighmaximumflowsole≥192mL/sPreoperative322additiongroup0001VoidingdysfunctionratesgroupsoutcomeidentifiedfindingscanserveguidepreoperativeconsultationsimilarproceduresClinicalOutcomeWomenPelvicOrganProlapseUnderwentTransvaginalMeshReconstructionSurgerysurgical

Similar Articles

Cited By

No available data.